Global HCP Transparency Study
Regulatory disclosure challenges and program guidance for Life Sciences companies
Can the game be changed? Is there an opportunity for the life sciences industry to come together—formally—to develop a global HCP transparency solution?
HCP Global Transparency Study: Regulatory disclosure challenges and program guidance for Life Sciences companies
HCP transparency requirements are similar in many countries which have existing laws and industry codes: the data elements are similar; the processes to collect and report the data are similar; and the roles and responsibilities required to operate a HCP transparency reporting solution are similar. Despite these similarities, however, we have observed that many companies are building essentially redundant systems, processes, and organizations in each country with a current or pending HCP transparency regulation.